A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

ABSTRACT: The purpose of this study is to determine the safety, tolerability, and preliminary efficacy of INCAGN02385 in participants with advanced malignancies.

DISEASE(S): Lymphoma, Large B-cell, Diffuse,Squamous Cell Carcinoma Of The Head And Neck (scchn),Microsatellite Instability,Carcinoma,Triple Negative Breast Neoplasms,Mesothelioma,Urothelial Carcinoma,Triple-negative Breast Cancer,Endometrial Neoplasms,Microsatellite Instability (msi)-high Endometrial Cancer,Lung Neoplasms,Carcinoma, Merkel Cell,Ovarian Cancer,Gastric Cancer (including Stomach And Gastroesophageal Junction [gej]),Advanced Solid Tumor,Hepatocellular Carcinoma,Cervical Cancer,Melanoma,Small Cell Lung Carcinoma,Melanoma (uveal Melanoma Excluded),Diffuse Large B-cell Lymphoma,Merkel Cell Carcinoma,Non-small Cell Lung Cancer (nsclc),Small Cell Lung Cancer (sclc),Renal Cell Carcinoma (rcc),Squamous Cell Carcinoma Of Head And Neck,Msi-high Colorectal Cancer,Esophageal Cancer

PROVIDER: 2273916 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR